Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Overview
Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences is a reputable scientific journal that publishes cutting-edge research in the field of pharmacy. With a focus on advancing pharmaceutical sciences, this journal provides a platform for researchers to share their findings, innovations, and insights. It covers a wide range of topics including drug discovery, pharmacology, pharmaceutical technology, and clinical pharmacy. Daru is a valuable resource for academics, professionals, and students in the pharmaceutical industry, contributing to the advancement of healthcare wor
Details
Details
Abbr.
Daru
Start
1990s
End
Continuing
Frequency
Quarterly
p-ISSN
1560-8115
e-ISSN
2008-2231
Country
Switzerland
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 6339
58
SJR / Ranks: 7196
625
CiteScore / Ranks: 2418
7.70
JIF / Ranks: 2654
3.6
Recent Articles
1.
Li J, Chen D, Zhao F, Cao W, Jin P
Daru
. 2025 Mar;
33(1):15.
PMID: 40085401
Background: Rituximab (RTX) is one of the treatment options for refractory myasthenia gravis (MG), yet the optimal dosing schedule remains undetermined. Our study aims to explore this issue and offer...
2.
3.
Fakhri B M, Roostaei G, Aghayani S, Shojamoradi M, Vesali B, Khoshnam Rad N
Daru
. 2025 Mar;
33(1):13.
PMID: 40072667
Introduction: Leukocytoclastic vasculitis (LCV) is a small-vessel inflammatory condition that can rarely occur as an adverse drug reaction (ADR). Vancomycin-induced LCV is an uncommon but potentially serious complication, particularly in...
4.
Burhanuddin H, Enggi C, Tangdilintin F, Saputra R, Putra P, Sartini S, et al.
Daru
. 2025 Feb;
33(1):12.
PMID: 40009294
No abstract available.
5.
Tavasoli Rostami A, Izadi M, Saberi M, Raei M, Soodmand M, Nasiri K, et al.
Daru
. 2025 Jan;
33(1):11.
PMID: 39751953
Background: The inappropriate use of antibiotics increases the costs of treatment, antibiotic resistance, increased disease length and duration of hospital stay. Objectives: The aim of this study was investigating the...
6.
Zarrinnahad H, Dehdast S, Fard G, Nourbakhsh M, Koohi M, Panahi G, et al.
Daru
. 2024 Dec;
33(1):10.
PMID: 39731629
Objective(s): Some forms of breast cancer such as triple-negative phenotype, are serious challenge because of high metastatic cases, high mortality and resistance to conventional therapy motivated the search for alternative...
7.
Hashem F, Elkhateeb D, Ali M, Abdel-Rashid R
Daru
. 2024 Dec;
33(1):9.
PMID: 39714544
Background: Bile salts enriched nanovesicles (bilosomes) have been attention worthy in the past few years due to their distinctive effect on the enhancement of drug delivery through various physiological administration...
8.
Fatriyah S, Nizardo N, Ramadon D
Daru
. 2024 Dec;
33(1):8.
PMID: 39704862
Background: High-performance liquid chromatography (HPLC) has emerged as a highly sensitive and versatile analytical technique for quantifying antihypertensive drugs, such as Captopril (CAP). This study focused on the optimization and...
9.
Mishra I, Chaudhary K, Sharma V, Krishna G, Mishra R
Daru
. 2024 Dec;
33(1):7.
PMID: 39694935
Objectives: Electroceuticals refers to the constantly growing disciplines of bioelectric and bioelectronic medication. These include a broad variety of devices that have been invented and are now being utilized in...
10.
Bashirynejad M, Soleymani F, Nikfar S, Kebriaeezadeh A, Majdzadeh R, Fatemi B, et al.
Daru
. 2024 Dec;
33(1):6.
PMID: 39688735
Objective: The main aim of this study was to explore and understand the emerging developments, changes, and patterns shaping the future of the pharmaceutical industry. The pharmaceutical industry is evolving...